Terms: = Lung cancer AND RAP1GDS1, P52306, 5910, MGC118861, MGC118859, GDS1, ENSG00000138698 AND Prognosis
5 results:
1. WDR74 rs11231247 contributes to the susceptibility and prognosis of non-small cell lung cancer.
Wu F; Wu H; Hu W; Zhang Z; Zhang X
Pathol Res Pract; 2023 Feb; 242():154318. PubMed ID: 36701849
[TBL] [Abstract] [Full Text] [Related]
2. Retrospective Data Analysis of Patients With Metastatic lung Adenocarcinoma With or Without
Moeller M; Schaedlich F; Schuette W
Cancer Control; 2022; 29():10732748221126949. PubMed ID: 36355617
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic and clinicopathological value of PD-L2 in lung cancer: A meta-analysis.
Lin X; Lin K; Lin C; Liu T; Ba M; Tang Y; Wang J; Zhou L; Wang J; Xiao C
Int Immunopharmacol; 2021 Feb; 91():107280. PubMed ID: 33370681
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of rare and complex mutations in EGFR and serum levels of soluble EGFR and its ligands in non-small cell lung carcinoma patients.
Haghgoo SM; Khosravi A; Mortaz E; Pourabdollah-Toutkaboni M; Seifi S; Sabour S; Allameh A
Clin Biochem; 2017 Apr; 50(6):293-300. PubMed ID: 27923629
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical characteristics and treatment analysis of primary breast lymphoma: 49 cases report].
Qiu LH; Wang HQ; Qian ZZ; Li W; Hou Y; Meng XR; Cui XZ; Hao XS
Zhonghua Wai Ke Za Zhi; 2010 May; 48(10):743-6. PubMed ID: 20646489
[TBL] [Abstract] [Full Text] [Related]